Dr. Michele Stanchina, DO

Dr. Stanchina practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Stanchina's NPI, 1740711456, was assigned on March 23, 2017. Dr. Stanchina graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2017. Dr. Stanchina holds Florida license OS20352.

Dr. Stanchina's primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Stanchina's primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Stanchina is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stanchina practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Stanchina's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Stanchina is board certified in internal medicine by the American Board of Internal Medicine. Dr. Stanchina is licensed in Florida.

CMS data shows 158 Medicare services from Dr. Stanchina across 4 procedure codes in 2024, for 56 Medicare patients. Medicare paid $14,808 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Stanchina in 2024. The largest group is 65 to 74, with 25 patients. 73% of them have high cholesterol, and 70% have high blood pressure. 30% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stanchina's median patient age at 68, with 53% women.

In 2024, Dr. Stanchina wrote 315 Medicare Part D claims for 26 patients. 95% of them were for generic drugs. CMS names the drug for 252 of them, across 7 drugs with 11 or more claims each, at $1,314 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Stanchina for performance year 2024, reported as part of a group. Dr. Stanchina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stanchina as offering telehealth.

Dmand AI links 14 papers to Dr. Stanchina, published from 2019 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Immunoconjugates. Dr. Stanchina has published most often in Am J Hematol. Dr. Stanchina's most frequent co-authors are Izidore Lossos, MD, Justin W. Taylor, MD and Juan Pablo Alderuccio, MD.

CMS Open Payments shows 14 general payments to Dr. Stanchina from 6 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 92% of the total. Adaptive Biotechnologies Corporation paid the most, $490. It also lists 1 research payment totaling $159 in 2024.

Dr. Stanchina graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2017.

Dr. Stanchina is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.